Healthcare - Press Releases

  • 1085 Press Releases ·
  • RSS
Published on Tue 15 Apr 2025 6:36:09 UTC
LONDON, April 15, 2025 /PRNewswire/ -- Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols S.A. to shareholders of Biotest:
Published on Tue 15 Apr 2025 6:36:08 UTC
Acquisition ofTheravia from Mrieux Equity Partners represents meaningful step forward in Norgine's strategy for sustainable growth, adding a complementary portfolio of rare disease medicines
Published on Tue 15 Apr 2025 6:36:04 UTC
VADUZ, Liechtenstein, April 15, 2025 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2024. The annual report is now available on the company's website.
Published on Tue 15 Apr 2025 6:30:03 UTC
Seventh Film in Award-Winning Series Highlights the Heroes on the Front Lines of Health Care
Published on Tue 15 Apr 2025 6:19:56 UTC
Richard Taite, Host of We're Out of Time Podcast (PRNewsfoto/Carrara Treatment Wellness & Spa)
Published on Tue 15 Apr 2025 6:19:46 UTC
Latest edition recognizes nearly 1,900 communities as "best."
Published on Tue 15 Apr 2025 6:17:03 UTC
VANCOUVER, BC, April 15, 2025 /PRNewswire/ -WELL Health Technologies Corp.(TSX: WELL) (the"Company"or"WELL"),a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce it has filed its audited annual financial statements for the fiscal year and fourth quarter ended December 31, 2024, the related management's discussion and analysis ("MD&A"), annual information form, and accompanying CEO and CFO certifications under its profile on SEDAR+ at www.sedarplus.ca.
Published on Fri 11 Apr 2025 6:06:16 UTC
MCKINNEY, Texas, April 10, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will announce its First Quarter 2025 financial results after the market closes on Wednesday, April 30, 2025.At that time, a copy of the Company's First Quarter 2025 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website, https://investors.globelifeinsurance.com/, under Financial Reports and Other Financial Information.
Published on Fri 11 Apr 2025 6:06:05 UTC
BOSTON, April 10, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company driving to change the standard of care for lumbardiscectomy patients with large annular defects by reducing reoperations for reherniations by 81% with its Barricaid Annular Closure Device, today announced the appointment of Keith Valentine as President and Chief Executive Officer. Mr. Valentine will also join the Board of Directors and will begin his role in early May.
Published on Fri 11 Apr 2025 6:05:55 UTC
Merck for Mothers' grant of half a million dollars will help expand the reach of Baby2Baby's initiative to combat the maternal health crisis across the country
Published on Fri 11 Apr 2025 6:05:54 UTC
Company to Participate in Upcoming Conferences
Published on Fri 11 Apr 2025 6:05:49 UTC
BLOOMFIELD, Conn., April 10, 2025 /PRNewswire/ --In an effort to aid local communities impacted by the Southern California wildfires, The Cigna Group and basketball legend Earvin "Magic" Johnson joined forces on a Bright Futures Carnival that provided Boys & Girls Club of Pasadena kids with a fun-filled day of activities, food and gifts - along with a special visit from the basketball legend himself.
Published on Fri 11 Apr 2025 6:05:39 UTC
ST. LOUIS, April 10, 2025 /PRNewswire/ --Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Nevada subsidiary, SilverSummit Healthplan, Inc.(SilverSummit), has been selected by the Nevada Department of Health and Human Services to provide services for its Medicaid managed care program. For the first time the program will include expansion of Medicaid Managed Care into rural and frontier service areas, communities that were previously fee-for-service. Subject to state approval, the five-year contract is expected to begin January 1, 2026, with a possible two-year extension.
Published on Fri 11 Apr 2025 6:05:31 UTC
SAN JUAN, Puerto Rico, April 10, 2025 /PRNewswire/ -- In Puerto Rico, where 90% of the population aged 65 or older takes daily medication, often managing 4 to 5 prescriptions concurrently, medication adherence and safety are paramount. Standardized packaging, while intended to streamline dispensing, can inadvertently lead to confusion, especially at night or during frequent power outages, with residents potentially facing approximately 90 power outages between May and September this year, averaging 18 outages per month.
Published on Fri 11 Apr 2025 6:05:30 UTC
XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high incidence of gastrointestinal side effects and modest efficacy compared to newer treatments limit its long-term adherence and competitive standing. Despite this, the growing obesity epidemic and XENICAL's established safety profile create opportunities for continued use, particularly in patients who require non-systemic treatment options.
Published on Fri 11 Apr 2025 6:05:19 UTC
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
Published on Fri 11 Apr 2025 6:03:24 UTC
Report Ignores Medicare Contractors' Attack on Patient Care and the Biden Administration's Inaction on Payment Reform
Published on Fri 11 Apr 2025 5:56:54 UTC
- Revenues +11.6%, Adjusted EBITDA +13.1%
Published on Fri 11 Apr 2025 5:56:47 UTC
SUZHOU, China, April 10, 2025 /PRNewswire/ -- EonveLab, a subsidiary of ImmVira Group ("ImmVira," or the "Company"), recently announced that its in-house developed engineered exosome product, MVR-EX103, developed for treating superficial skin depressions, has successfully passed the review of theInternational Cosmetic Ingredient Nomenclature Committee ("INC") and been officially granted a standardized International Nomenclature Cosmetic Ingredient ("INCI")name under the designation "Exosome." This marks the first engineered exosome worldwide to receive an INCI designation, highlighting ImmVira's leadership in the field and a significant advancement in the development of next-generation cosmetic ingredients.
Published on Fri 11 Apr 2025 5:53:30 UTC
BARGERSVILLE, Ind., April 10, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, PaulDelbert Winchester, MD is acknowledged as a Top Pinnacle Neonatologist for his contributions in Neonatology.
Published on Fri 11 Apr 2025 5:45:03 UTC
TORONTO, April 10, 2025 /PRNewswire/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that it will host a shareholder conference call to provide an update on its recent strategic developments, commercial progress, regulatory initiatives, and the next phase of its business growth.
Published on Fri 11 Apr 2025 5:44:53 UTC
STUART, Fla., April 10, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to announce the appointment of a new independent director, Sanjay Shrestha, to the Company's Board of Directors (the "Board"). Mr. Shrestha will serve as a member of the Audit Committee, Compensation Committee and the Nominating and Corporate Governance Committee of the Board.
Published on Fri 11 Apr 2025 5:44:34 UTC
- Annonce d'une initiative mondiale pour la sant personnalise et la mdecine prventive lors de l'vnement
Published on Fri 11 Apr 2025 5:44:23 UTC
BIRMINGHAM, Ala., April 10, 2025 /PRNewswire/ -- Alabama Ophthalmology Associates ("AOA") experienced a data security incident that involved personal and / or protected health information belonging to certain current and former patients and has provided notice of this incident to impacted individuals. AOA has sent notification of this incident to potentially impacted individuals and has provided resources to assist them.
Published on Fri 11 Apr 2025 5:44:22 UTC
SAN DIEGO and CALGARY, AB, April 10, 2025 /PRNewswire/ -- Oncolytics BiotechInc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, has entered into a share purchase agreement (SPA) with Alumni Capital LP (Alumni), an institutional investor. This partnership will provide Oncolytics with a flexible source of funding, enabling the Company to progress pelareorep toward key clinical milestones and minimize dilution to create and sustain shareholder value. The SPA allows Oncolytics to be judicious and plan for the timing and amount of any equity sales, which will be critical as pelareorep's development continues.